Last reviewed · How we verify

NCT05375721

Prevention of PONV With Traditional Chinese Medicine

Status unknown NA Last updated 23 September 2022
What this trial tests

NA trial testing ST36 acupoint injection in Postoperative Nausea and Vomiting in 300 participants. Status unknown.

Timeline
23 September 2022
Primary endpoint
1 February 2024
1 May 2024

Quick facts

Lead sponsorThe Second Hospital of Anhui Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment300
Start date23 September 2022
Primary completion1 February 2024
Estimated completion1 May 2024
Sites7 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

The Second Hospital of Anhui Medical University

Who can join

Adults 18 to 65, female only, with Postoperative Nausea and Vomiting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative nausea and vomiting (PONV) is particularly one of the most common complications after laparoscopic sleeve gastrectomy (LSG). It can lead to serious adverse events and delayed activity, and prolong the time of rehabilitation and discharge. Numbers of studies have been focused on identifying risk factors and therapies of PONV. Unfortunately, there' no consistent comments for PONV prevention in women after LSG. Notably, Zusanli (ST36) acupoint and anisodamine have been evidenced to treat various gastrointestinal conditions. The primary outcome of this study was to evaluate the impact of anisodamine injection in ST36 on PONV in women following bariatric surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Nausea and Vomiting

Currently open trials in the same condition.

Other The Second Hospital of Anhui Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05375721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing